Burgon & Ball wins alleged design rights battle

Burgon & Ball has had success challenging copyright issues after becoming members of the Anti Copying in Design (ACID) group.

A representative of the Sheffield-based garden tools manufacturer said:

"We're taking action where it happens. It happens a lot. We've had our brushes and home allotment planters copied. We seem to be the innovators and everyone keeps jumping on the bandwagon. We've taken people to court and won the battles and will carry on doing so."

The company challenged Proteam, Solus, Apollo and Greentree Garden Products over intellectual proprty rights to products in their Home Allotment range. The four companies agreed not to produce further lookalike products and to hand over stock.

ACID-accredited lawyers McDaniel & Co issued cease and desist letters.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Sign up now
Already registered?
Sign in

Read These Next



These robust plants can repeat flower from April to October and nice foliage adds interest, says Miranda Kimberley.

Business Planning - Brace now for Brexit impact

Business Planning - Brace now for Brexit impact

Neville Stein advises how businesses can act now to protect themselves against higher plant import costs after the Brexit deadline.

How will Westland buying Gardman impact the garden centre supply market?

How will Westland buying Gardman impact the garden centre supply market?

Follow us on:
  • Facebook
  • LinkedIn
  • Twitter
  • Google +


The Horticulture Week Business Awards is now open for entries

Horticulture Jobs
More Horticulture Jobs

Horticulture Week Top 100 GARDEN CENTRES 2018

See our exclusive RANKING of garden centre performance by annual turnover plus the FULL REPORT AND ANALYSIS of the market drawing on our garden retail industry-exclusive research

Garden Centre Prices

Peter Seabrook

Inspiration and insight from travels around the horticultural world

Read more Peter Seabrook articles

Neville Stein

Business advice from Neville Stein, MD of business consultancy Ovation

Read latest articles